Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: The risk of heart damage after a booster shot | A key recall | Same-day discharge after TAVR
Saturday, March 26, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Risk of vaccine-related heart damage after booster shot lower than it was after first 2 doses

The new analysis included data from more than 126,000 vaccinations. 

READ MORE >
Vaccination
Share on Twitter Share on Facebook Share on Linkedin

Risk of vaccine-related heart damage after booster shot lower than it was after first 2 doses

Share on Twitter Share on Facebook Share on Linkedin
Vaccination
The new analysis included data from more than 126,000 vaccinations. 
READ MORE >

FDA announces recall of hypertension medications due to potential cancer risk

The voluntary recall includes quinapril HCl/hydrochlorothiazide tablets sold by Pfizer and authorized generics of that same medication. 

READ MORE >
These quinapril HCl/hydrochlorothiazide tablets, which Pfizer sells under the name Accuretic, are included in the voluntary FDA recall.
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of hypertension medications due to potential cancer risk

Share on Twitter Share on Facebook Share on Linkedin
These quinapril HCl/hydrochlorothiazide tablets, which Pfizer sells under the name Accuretic, are included in the voluntary FDA recall.
The voluntary recall includes quinapril HCl/hydrochlorothiazide tablets sold by Pfizer and authorized generics of that same medication. 
READ MORE >

New-look imaging technique could change the way we see blood vessels

The new method, still being tested with mouse models, could help clinicians see blood vessels with improved clarity. 

READ MORE >
The new imaging method VascuViz includes a quick-setting polymer mixture to fill blood vessels and make them visible in multiple imaging techniques. It enables visualization of the structure of a tissue’s vasculature, which in conjunction with detailed mathematical models or complementary images of other tissue elements can clarify the complex role of blood flow in health and disease. Watch a video example of this technology
Share on Twitter Share on Facebook Share on Linkedin

New-look imaging technique could change the way we see blood vessels

Share on Twitter Share on Facebook Share on Linkedin
The new imaging method VascuViz includes a quick-setting polymer mixture to fill blood vessels and make them visible in multiple imaging techniques. It enables visualization of the structure of a tissue’s vasculature, which in conjunction with detailed mathematical models or complementary images of other tissue elements can clarify the complex role of blood flow in health and disease. Watch a video example of this technology
The new method, still being tested with mouse models, could help clinicians see blood vessels with improved clarity. 
READ MORE >

Same-day discharge after TAVR is feasible and safe, new Cleveland Clinic study confirms

Cleveland Clinic turned to same-day discharge after TAVR during the COVID-19 pandemic, finding considerable success. 

READ MORE >
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings
Share on Twitter Share on Facebook Share on Linkedin

Same-day discharge after TAVR is feasible and safe, new Cleveland Clinic study confirms

Share on Twitter Share on Facebook Share on Linkedin
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings
Cleveland Clinic turned to same-day discharge after TAVR during the COVID-19 pandemic, finding considerable success. 
READ MORE >

VIDEO: Office-based cardiac CT and FFR-CT offer a new business model

In a new video, Evans Pap­pas, MD, and Sujith Kalathiveetil, MD, both of Duly Health and Care in suburban Chicago, explain the shift toward office-based cardiac CT evaluations and the role of FFR-CT. 

READ MORE >
A cardiac CT scan being performed on a Cardiograph dedicated cardiac CT scanner at a Duly Health and Care outpatient clinic. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Office-based cardiac CT and FFR-CT offer a new business model

Share on Twitter Share on Facebook Share on Linkedin
A cardiac CT scan being performed on a Cardiograph dedicated cardiac CT scanner at a Duly Health and Care outpatient clinic. Photo by Dave Fornell
In a new video, Evans Pap­pas, MD, and Sujith Kalathiveetil, MD, both of Duly Health and Care in suburban Chicago, explain the shift toward office-based cardiac CT evaluations and the role of FFR-CT. 
READ MORE >

Thrombolysis vs. surgery for prosthetic valve thrombosis

The three-month mortality rate was 2.4% after thrombolysis and 18.7% after surgery.

READ MORE >
Examples of prosthetic heart valve thrombus formation on the valve leaflets. A new study shows better outcomes using tPA vs. surgery to remove the clots. Valve thrombosis. Images from Mayo Clinic
Share on Twitter Share on Facebook Share on Linkedin

Thrombolysis vs. surgery for prosthetic valve thrombosis

Share on Twitter Share on Facebook Share on Linkedin
Examples of prosthetic heart valve thrombus formation on the valve leaflets. A new study shows better outcomes using tPA vs. surgery to remove the clots. Valve thrombosis. Images from Mayo Clinic
The three-month mortality rate was 2.4% after thrombolysis and 18.7% after surgery.
READ MORE >

Bariatric surgery associated with lower risk of death and cardiovascular disease

Researchers examined data from 39 different studies, focusing on mortality rates and adverse cardiovascular outcomes. 

READ MORE >
Cleveland Clinic Bariatric
Share on Twitter Share on Facebook Share on Linkedin

Bariatric surgery associated with lower risk of death and cardiovascular disease

Share on Twitter Share on Facebook Share on Linkedin
Cleveland Clinic Bariatric
Researchers examined data from 39 different studies, focusing on mortality rates and adverse cardiovascular outcomes. 
READ MORE >

VIDEO: American College of Cardiology working to propel cardiovascular innovation

Ami Bhatt, MD, explained how the ACC is working to advance new technologies that can improve patient care.

READ MORE >
Ami Bhatt, MD, the American College of Cardiology (ACC) Chief Innovation Officer, and an Adult Congenital Heart Disease cardiologist at Mass General Hospital (MGH). She is viewed one of the national experts on telecardiology, having been the former director of telecardiology at Mass General during 2020-2021.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: American College of Cardiology working to propel cardiovascular innovation

Share on Twitter Share on Facebook Share on Linkedin
Ami Bhatt, MD, the American College of Cardiology (ACC) Chief Innovation Officer, and an Adult Congenital Heart Disease cardiologist at Mass General Hospital (MGH). She is viewed one of the national experts on telecardiology, having been the former director of telecardiology at Mass General during 2020-2021.
Ami Bhatt, MD, explained how the ACC is working to advance new technologies that can improve patient care.
READ MORE >

AI models capable of identifying RV, LV dysfunction in ECGs

Specialists used EHR data, imaging results and natural language processing to bring their advanced AI models to life. 

READ MORE >
Electrocardiograms analyzed by AI can offer information about mortality risk.
Share on Twitter Share on Facebook Share on Linkedin

AI models capable of identifying RV, LV dysfunction in ECGs

Share on Twitter Share on Facebook Share on Linkedin
Electrocardiograms analyzed by AI can offer information about mortality risk.
Specialists used EHR data, imaging results and natural language processing to bring their advanced AI models to life. 
READ MORE >

DOACs may reduce the risk of dementia among AFib patients by 50%

Nearly 19,000 patients with newly diagnosed atrial fibrillation were included in the team's analysis. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

DOACs may reduce the risk of dementia among AFib patients by 50%

Share on Twitter Share on Facebook Share on Linkedin
Nearly 19,000 patients with newly diagnosed atrial fibrillation were included in the team's analysis. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme